Drugs shows promise for reducing inflammation caused by TBI
An experimental drug called MW151 appears to suppress levels of a pro-inflammatory cytokine, which reduces inflammation without interfering with the brain’s repair process....
read moreLearningRx1
An experimental drug called MW151 appears to suppress levels of a pro-inflammatory cytokine, which reduces inflammation without interfering with the brain’s repair process....
read moreA 25-year-old football player with CTE who had 10 concussions beginning at age 8 provided the first autopsy-confirmed CTE case in which researchers could include neuropsychological testing to document the type of cognitive issues that were present....
read moreResearchers isolated a toxic form of tau protein from animals that had experienced a TBI then injected into other animals and found that they developed the same type of mental impairments caused by Alzheimer’s....
read moreResearchers from VA Puget Sound Health Care System and the University of Washington have found that the cerebellum is particularly vulnerable to repetitive mild TBI and the more blasts vets are exposed to, the more lasting changes in their...
read moreA consensus panel of expert neuropathologists has found that CTE has a pathognomonic signature in the brain and is therefore a unique disease....
read moreA new study has found that heading the ball is the most common cause for soccer players to sustain a concussion....
read more